SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-24-003193
Filing Date
2024-04-02
Accepted
2024-04-02 17:27:52
Documents
1
Period of Report
2024-03-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 17896
  Complete submission text file 0001562180-24-003193.txt   19564
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Issuer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)

Mailing Address 4025 SORRENTO VALLEY BLVD. SAN DIEGO CA 92121
Business Address
Paggiarino Dario A. (Reporting) CIK: 0001574261 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51122 | Film No.: 24815765